U.S. FDA clears Vivani Medical's Investigational New Drug Application for NPM-119. Vivani’s LIBERATE-1 trial to test innovative implant's effectiveness and safety in type 2 diabetes care. See how Matt ...
A Cochrane Systematic Review that set out to assess the effectiveness and tolerability of subdermal implantable contraceptives compared to other reversible methods of contraception found that they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback